fda glp 1 decision The Latest GLP-1 Oral Medication, Foundayo: What Employers Need to Know GLP-1 medications may not work
Description
The balance between germline s...
Discover why prices matter and what alternatives exist today
Indeed, studies on the use of GLP-1Ra mostly included patients with diabetes who were administered a dose used in this condition, did not have adequate bone parameters as primary endpoints, and had short follow-up periods
New real-world research presented at the AAAAI Annual Meeting suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may significantly reduce asthma exacerbations in overweight and obese adults without diabetes pointing to a potential new therapeutic strategy for a difficult-to-treat population.
These results suggest that exendin-4-induced suppression may be mediated by a distinct Gs/cAMP-PKA/IP3/Ca2+/CaM/CaMKII signaling pathway, following the activation of GLP-1Rs.
Dr Lauren Struszczak joins the Healthcare Today Podcast to talk about why nutrition is central to supporting patients on weight-loss medications.
